1. Home
  2. INTS vs EDUC Comparison

INTS vs EDUC Comparison

Compare INTS & EDUC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INTS
  • EDUC
  • Stock Information
  • Founded
  • INTS 2012
  • EDUC 1965
  • Country
  • INTS United States
  • EDUC United States
  • Employees
  • INTS N/A
  • EDUC N/A
  • Industry
  • INTS Biotechnology: Pharmaceutical Preparations
  • EDUC Consumer Specialties
  • Sector
  • INTS Health Care
  • EDUC Consumer Discretionary
  • Exchange
  • INTS Nasdaq
  • EDUC Nasdaq
  • Market Cap
  • INTS 10.9M
  • EDUC 11.4M
  • IPO Year
  • INTS 2023
  • EDUC N/A
  • Fundamental
  • Price
  • INTS $0.23
  • EDUC $1.12
  • Analyst Decision
  • INTS Strong Buy
  • EDUC
  • Analyst Count
  • INTS 4
  • EDUC 0
  • Target Price
  • INTS $4.50
  • EDUC N/A
  • AVG Volume (30 Days)
  • INTS 4.0M
  • EDUC 312.6K
  • Earning Date
  • INTS 11-12-2025
  • EDUC 10-09-2025
  • Dividend Yield
  • INTS N/A
  • EDUC N/A
  • EPS Growth
  • INTS N/A
  • EDUC N/A
  • EPS
  • INTS N/A
  • EDUC N/A
  • Revenue
  • INTS N/A
  • EDUC $31,304,000.00
  • Revenue This Year
  • INTS N/A
  • EDUC N/A
  • Revenue Next Year
  • INTS N/A
  • EDUC N/A
  • P/E Ratio
  • INTS N/A
  • EDUC N/A
  • Revenue Growth
  • INTS N/A
  • EDUC N/A
  • 52 Week Low
  • INTS $0.19
  • EDUC $0.92
  • 52 Week High
  • INTS $4.30
  • EDUC $2.49
  • Technical
  • Relative Strength Index (RSI)
  • INTS 32.86
  • EDUC 46.70
  • Support Level
  • INTS $0.27
  • EDUC $1.08
  • Resistance Level
  • INTS $0.30
  • EDUC $1.16
  • Average True Range (ATR)
  • INTS 0.02
  • EDUC 0.06
  • MACD
  • INTS -0.00
  • EDUC 0.01
  • Stochastic Oscillator
  • INTS 6.39
  • EDUC 64.71

About INTS Intensity Therapeutics Inc. Common stock

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.

About EDUC Educational Development Corporation

Educational Development Corp is the United States trade publisher of the line of educational children's books produced in the United Kingdom. Its business activity functions with two reportable segments: PaperPie and Publishing. The Publishing Division segment markets its products to retail accounts, which include books, school supplies, toy and gift stores and museums, through commissioned sales representatives, trade and specialty wholesalers and an internal telesales group.

Share on Social Networks: